Dabur wins temporary stay on FSSAI’s ‘100%’ claim curbs as ₹150 crore inventory faces risk

The Delhi High Court has stayed FSSAI restrictions on Dabur’s “100 per cent” product claims until August 24. Dabur says affected inventory is worth ₹150 crore; Blinkit has disabled listings, while the company updates labels and advertising.

— Source publishedMon, 10 Aug, 2026, 14:33 IST·First seen Mon, 10 Aug, 2026, 14:41 IST·Source Business Standard · Companies

What happened

Dabur India · Delhi High Court stayed FSSAI’s restrictions on Dabur’s “100 per cent” product claims until August 24. Dabur says ₹150 crore of inventory is at

Key facts

  • ₹150 crore inventory at risk
  • August 4
  • August 24

Why this matters

Treat the dispute as a diligence flag for FMCG targets and partnerships, with particular focus on substantiation standards, labeling workflows and platform-listing resilience.

What to watch

  • Delhi High Court’s post-August 24 direction and any extension, modification or vacation of the stay.
  • FSSAI clarification, guidance note or enforcement notice defining acceptable use of "100%" claims.
  • Blinkit relisting behavior and whether Zepto, Swiggy Instamart, Amazon, Flipkart and modern trade follow similar restrictions.
  • Evidence of enforcement against peer FMCG brands using "100%", "pure", "natural" or equivalent absolute claims.
  • Dabur disclosures on relabeling expense, inventory provisions, lost sales or channel returns.
  • Consumer-affairs complaints, competitor challenges or advertising-regulator actions tied to the disputed wording.
  • Accelerate label, artwork and ad-copy alternatives that preserve product differentiation without unsupported absolute claims.
  • Provide Blinkit, other marketplaces and distributors with court-stay documentation, approved listing language and SKU-level compliance status.
  • Audit all absolute and purity claims across Dabur’s portfolio, including digital storefront images, influencer content and retailer-created listings.
  • Build substantiation dossiers for each affected claim, including ingredient specifications, manufacturing-process evidence and consumer-facing qualification language.
  • Prepare inventory-routing and promotion plans to clear legally sellable stock before any adverse ruling or platform policy change.
  • Monitor competitors’ claim language and consider seeking consistent enforcement rather than allowing asymmetric delistings.